Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current Assets
Cash	$ 203,622	$ 232,984
Trade accounts receivable, net	299,338	154,436
Inventory, net	138,494	61,051
Total Current Assets	641,454	448,471
Current Liabilities
Accounts payable and accrued expenses	336,963	167,481
Notes payable	100,000	100,000
Total Current Liabilities	436,963	267,481
Immudyne, Inc. Stockholders' equity
Common stock, $0.01 par value; 50,000,000 shares authorized, 32,010,375 shares issued and outstanding	320,103	320,103
Additional paid-in capital	8,405,180	8,366,313
Accumulated (deficit)	(8,648,387)	(8,586,338)
Total Immudyne, Inc. Stockholders' Equity	76,896	100,078
Noncontrolling interests	127,595	80,912
Total Stockholders' Equity	204,491	180,990
Total Liabilities and Stockholders' Equity	$ 641,454	$ 448,471

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.